markgw, not sure you'll get much from the LITHIUM thread, particularly around it being sought after as a potential rare gem. My take is that the company was trying to flag that it expects these assays to be strong as pegmatites mineralogical composition (i.e. core volume) has fewer number of unusual minerals and if anything is dominated by large green spodumene crystals. Processing to a spodumene concentrate would generally (but not always) be a simply proposition when there is consistency of mineral elements being process through flow sheet. Hence why I don't think this wording was an accident:
"Spodumene mineralisation is almost ubiquitous throughout the Grants pegmatite, and has been intersected consistently over 40m-50m in all three fully cored diamond drillholes"
I'm no expert so please take the above with a grain of salt. If I was a holder I'd think about emailing the company directly as I'm sure they'd be happy to provide a response to a shareholders at present.
- Forums
- ASX - By Stock
- CXO:Medium to Long Term Hold
markgw, not sure you'll get much from the LITHIUM thread,...
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CXO (ASX) to my watchlist
|
|||||
Last
12.0¢ |
Change
0.010(9.09%) |
Mkt cap ! $256.4M |
Open | High | Low | Value | Volume |
11.5¢ | 12.5¢ | 11.0¢ | $3.037M | 25.36M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 318278 | 12.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 2878347 | 41 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 268278 | 0.120 |
40 | 2995146 | 0.115 |
60 | 4820343 | 0.110 |
43 | 4085339 | 0.105 |
85 | 4725746 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 2878347 | 41 |
0.130 | 1714806 | 38 |
0.135 | 1280459 | 21 |
0.140 | 837938 | 9 |
0.145 | 762740 | 16 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
CXO (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online